Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Eliska Dvorackova, Martin Sima, Kristyna Vyskocilova, Tereza Kotowski, Kateřina Dunovská, Eva Klapkova, Jan Havlin, Robert Lischke & Ondrej Slanar. (2023) Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients. Journal of Chemotherapy 0:0, pages 1-10.
Read now
Read now
Adam G. Stewart & David L. Paterson. (2021) How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy 22:14, pages 1857-1870.
Read now
Read now
Hassan E. Eldesouky, Nadia A. Lanman, Tony R. Hazbun & Mohamed N. Seleem. (2020) Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs. Virulence 11:1, pages 1466-1481.
Read now
Read now
Briana L. Scott, Chi D. Hornik & Kanecia Zimmerman. (2020) Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population. Expert Opinion on Drug Metabolism & Toxicology 16:7, pages 605-616.
Read now
Read now
Jamie John, Angela Loo, Shawn Mazur & Thomas J. Walsh. (2019) Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 881-895.
Read now
Read now
Ya-Lin Chang, Shang-Jie Yu, Joseph Heitman, Melanie Wellington & Ying-Lien Chen. (2017) New facets of antifungal therapy. Virulence 8:2, pages 222-236.
Read now
Read now
María Victoria Castelli, Estefanía Butassi, María Candida Monteiro, Laura A Svetaz, Francisca Vicente & Susana A Zacchino. (2014) Novel antifungal agents: a patent review (2011 – present). Expert Opinion on Therapeutic Patents 24:3, pages 323-338.
Read now
Read now
Articles from other publishers (45)
Joseph Pechacek, Taura Webb, Elise M N Ferré, Monica M Schmitt, Thomas DiMaggio, Dale Kobrin, Suraj Rajasimhan, Ben Colton, Russell E Lewis, David Andes, Alejandro Herrera, Dima Hammoud, Seyedmojtaba Seyedmousavi, Sarfaraz Hasni, Jonathan Bolaños, Behdad Afzali & Michail S Lionakis. (2023)
Successful Treatment of
Paecilomyces variotii
Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity
. Open Forum Infectious Diseases 10:8.
Crossref
Crossref
Marjorie Vieira Batista, Maria Piedad Ussetti, Ying Jiang, Dionysios Neofytos, Anita Cassoli Cortez, Diego Feriani, Jayr Schmidt-Filho, Ivan Leonardo Avelino França-Silva, Issam Raad & Ray Hachem. (2023) Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study. Journal of Fungi 9:2, pages 166.
Crossref
Crossref
Nerea Jauregizar, Guillermo Quindós, Sandra Gil-Alonso, Elena Suárez, Elena Sevillano & Elena Eraso. (2022) Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?. Journal of Fungi 8:7, pages 727.
Crossref
Crossref
Andrea M. Burden, Lucy Hausammann, Alessandro Ceschi, Hugo Kupferschmidt & Stefan Weiler. (2022) Observational cross-sectional case study of toxicities of antifungal drugs. Journal of Global Antimicrobial Resistance 29, pages 520-526.
Crossref
Crossref
Meltem Ezgi Durgun, Emine Kahraman, Mayram Hacıoğlu, Sevgi Güngör & Yıldız Özsoy. (2021) Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies. Drug Delivery and Translational Research 12:3, pages 662-675.
Crossref
Crossref
Meltem Ezgi Durgun, Burcu Mesut, Mayram Hacıoğlu, Sevgi Güngör & Yıldız Özsoy. (2022) Optimization of the Micellar-Based In Situ Gelling Systems Posaconazole with Quality by Design (QbD) Approach and Characterization by In Vitro Studies. Pharmaceutics 14:3, pages 526.
Crossref
Crossref
Shaimaa Eissa, Reham Khedr, Marwa Romeih, Lama Halaby, Mervat Elanany & Youssef Madney. (2022) Clinical Characteristics and Outcome of Invasive Fungal Sinusitis in Children with Hematological Malignancies. Medical Mycology.
Crossref
Crossref
Jean Flanagan, Mathievathaniy Muthucumaru & Alison Thomas. (2021) Occult Candida bezoar (fungal ball) post ureteric stent insertion. Journal of Paediatrics and Child Health 57:12, pages 2005-2007.
Crossref
Crossref
Junais Koleri, Ahmad Al Bishawi, Israa' Al-Sheikh, Salman Qureshi, Muna AlMaslamani & Hamad Abdelhadi. (2021) Beware of covert enemies: Candida orthopsilosis malignant otitis externa with base of the skull osteomyelitis, a case report and review of literature. IDCases 25, pages e01163.
Crossref
Crossref
Léa Ponderand, Patricia Pavese, Danièle Maubon, Emmanuelle Giraudon, Thomas Girard, Caroline Landelle, Max Maurin & Yvan Caspar. (2020) Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS. Annals of Clinical Microbiology and Antimicrobials 19:1.
Crossref
Crossref
Meltem E. Durgun, Emine Kahraman, Sevgi Güngör & Yıldız Özsoy. (2020) Optimization and Characterization of Aqueous Micellar Formulations for Ocular Delivery of an Antifungal Drug, Posaconazole. Current Pharmaceutical Design 26:14, pages 1543-1555.
Crossref
Crossref
Tingjunhong Ni, Lei Pang, Zhan Cai, Fei Xie, Zichao Ding, Yumeng Hao, Ran Li, Shichong Yu, Xiaoyun Chai, Ting Wang, Yongsheng Jin, Dazhi Zhang & Yuanying Jiang. (2019) Design, synthesis, and in vitro antifungal evaluation of novel triazole derivatives bearing alkynyl side chains. Journal of Saudi Chemical Society 23:5, pages 576-585.
Crossref
Crossref
Maria Kotsopoulou, Christina Papadaki, Konstantinos Anargyrou, Alexandros Spyridonidis, Ioannis Baltadakis, Helen A. Papadaki, Maria Angelopoulou, Vasiliki Pappa, Kleoniki Liakou, Manto Tzanetakou, Marina Moustaka & George Vassilopoulos. (2019) Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study. Infectious Diseases and Therapy 8:2, pages 255-268.
Crossref
Crossref
Prabhuodeyara Math Gurubasavaraj & Jasmith Shivayya Charantimath. (2019) Recent Advances in Azole Based Scaffolds as Anticandidal Agents. Letters in Drug Design & Discovery 16:5, pages 492-501.
Crossref
Crossref
Galina I. Lepesheva, Laura Friggeri & Michael R. Waterman. (2018) CYP51 as drug targets for fungi and protozoan parasites: past, present and future. Parasitology 145:14, pages 1820-1836.
Crossref
Crossref
Elaine P. Cunha-Azevedo, Karen R. Py-Daniel, Marigilson P. Siqueira-Moura, Anamélia L. Bocca, Maria S.S. Felipe, Antonio C. Tedesco, Osmindo R. Pires Junior, Carolina M. Lucci & Ricardo B. Azevedo. (2018) In vivo evaluation of the efficacy, toxicity and biodistribution of PLGA-DMSA nanoparticles loaded with itraconazole for treatment of paracoccidioidomycosis. Journal of Drug Delivery Science and Technology 45, pages 135-141.
Crossref
Crossref
J. Scott Fites, Michael Gui, John F. Kernien, Paige Negoro, Zeina Dagher, David B. Sykes, Jeniel E. Nett, Michael K. Mansour & Bruce S. Klein. (2018) An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections. PLOS Pathogens 14:5, pages e1007073.
Crossref
Crossref
Whitley M. Yi, Kelly E. Schoeppler, Jaclyn Jaeger, Scott W. Mueller, Robert MacLaren, Douglas N. Fish & Tyree H. Kiser. (2017) Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study. Annals of Clinical Microbiology and Antimicrobials 16:1.
Crossref
Crossref
Adam J. McShane & Sihe Wang. (2017) Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantitation of 5 azole antifungals and 1 active metabolite. Clinica Chimica Acta 474, pages 8-13.
Crossref
Crossref
Giovanna Fatiguso, Fabio Favata, Ilaria Zedda, Amedeo De Nicolò, Jessica Cusato, Valeria Avataneo, Giovanni Di Perri & Antonio D’Avolio. (2017) A simple high performance liquid chromatography–mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. Journal of Pharmaceutical and Biomedical Analysis 145, pages 718-724.
Crossref
Crossref
Andrew Borman, Mark Fraser, Michael Palmer, Adrien Szekely, Marian Houldsworth, Zoe Patterson & Elizabeth Johnson. (2017) MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method. Journal of Fungi 3:2, pages 27.
Crossref
Crossref
Daniela StelzerAlexandra WeberFranziska IhleSandhya MatthesFelix CeelenGregor ZimmermannNikolaus KneidingerRene SchrammHauke Winter, Michael Zoller, Michael VogeserJuergen BehrClaus Neurohr. (2017) Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability. Therapeutic Drug Monitoring 39:2, pages 93-101.
Crossref
Crossref
Blanca Huertas, Daniel Prieto, Aida Pitarch, Concha Gil, Jesús Pla & Rosalía Díez-Orejas. (2016)
Serum Antibody Profile during Colonization of the Mouse Gut by
Candida albicans
: Relevance for Protection during Systemic Infection
. Journal of Proteome Research 16:1, pages 335-345.
Crossref
Crossref
Angela Haßler, Thomas Lehrnbecher, Peter Bader & Thomas Klingebiel. 2017. Haploidentical Stem Cell Transplantation. Haploidentical Stem Cell Transplantation
67
93
.
Me-Linh Luong, Mona Al-Dabbagh, Andreas H. Groll, Zdenek Racil, Yasuhito Nannya, Dimitra Mitsani & Shahid Husain. (2016) Utility of voriconazole therapeutic drug monitoring: a meta-analysis. Journal of Antimicrobial Chemotherapy 71:7, pages 1786-1799.
Crossref
Crossref
David Andes, Nkechi Azie, Hongbo Yang, Rachel Harrington, Caroline Kelley, Ruo-Ding Tan, Eric Q. Wu, Billy Franks, Rita Kristy, Edward Lee, Nikhil Khandelwal & James Spalding. (2016) Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients. Antimicrobial Agents and Chemotherapy 60:6, pages 3398-3406.
Crossref
Crossref
G. Venton, H. Adam, J. Colle, Y. Labiad, C. Mercier, V. Ivanov, P. Suchon, R. Fanciullino, L. Farnault & R. Costello. (2016) Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia. Médecine et Maladies Infectieuses 46:4, pages 226-229.
Crossref
Crossref
Bart G. J. Dekkers, Martijn Bakker, Kim C. M. van der Elst, Marieke G. G. Sturkenboom, Anette Veringa, Lambert F. R. Span & Jan-Willem C. Alffenaar. (2016) Therapeutic Drug Monitoring of Posaconazole: an Update. Current Fungal Infection Reports 10:2, pages 51-61.
Crossref
Crossref
Jennifer L. Horan-Saullo & Barbara D. Alexander. 2016. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine
661
681.e16
.
Nicolette R. Holt & Karin A. Thursky. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity
77
96
.
Diana Pisa, Ruth Alonso, Alberto Rábano, Izaskun Rodal & Luis Carrasco. (2015) Different Brain Regions are Infected with Fungi in Alzheimer’s Disease. Scientific Reports 5:1.
Crossref
Crossref
J. D. Lemetayer, P. M. Dowling, S. M. Taylor & M. G. Papich. (2015) Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing. Journal of Veterinary Pharmacology and Therapeutics 38:5, pages 451-456.
Crossref
Crossref
Yang Ning, Junqi Ling & Christine D. Wu. (2015) Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species. Archives of Oral Biology 60:10, pages 1565-1570.
Crossref
Crossref
Natasha N. Pettit & Peggy L. Carver. (2015) Isavuconazole. Annals of Pharmacotherapy 49:7, pages 825-842.
Crossref
Crossref
L.L. de Wall, M.M.C. van den Heijkant, A. Bökenkamp, C.F. Kuijper, H.J.R. van der Horst & T.P.V.M. de Jong. (2015) Therapeutic approach to Candida bezoar in children. Journal of Pediatric Urology 11:2, pages 81.e1-81.e7.
Crossref
Crossref
Meinolf Karthaus, Thomas Lehrnbecher, Hans-Peter Lipp, Stefan Kluge & Dieter Buchheidt. (2015) Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach. Annals of Hematology 94:4, pages 547-556.
Crossref
Crossref
Madhukar S. Patel, Alissa J. Wright, Rachel Kohn, James F. Markmann, Camille N. Kotton & Parsia A. Vagefi. (2015) Successful long-term management of invasive cerebral fungal infection following liver transplantation. Mycoses 58:3, pages 181-186.
Crossref
Crossref
Angela Haßler, Luciana Porto & Thomas Lehrnbecher. (2015) Cerebral Fungal Infection in Pediatric Cancer Patients. Current Fungal Infection Reports 9:1, pages 6-14.
Crossref
Crossref
Kyung Myung & Carla J.R. Klittich. (2015) Can agricultural fungicides accelerate the discovery of human antifungal drugs?. Drug Discovery Today 20:1, pages 7-10.
Crossref
Crossref
H. Karl Greenblatt & David J. Greenblatt. (2014) Liver injury associated with ketoconazole: Review of the published evidence. The Journal of Clinical Pharmacology 54:12, pages 1321-1329.
Crossref
Crossref
Georg Maschmeyer & Thomas F. Patterson. (2014) Our 2014 approach to breakthrough invasive fungal infections. Mycoses 57:11, pages 645-651.
Crossref
Crossref
F. Javier Pastor & Josep Guarro. (2014) Treatment of Aspergillus terreus infections: A clinical problem not yet resolved. International Journal of Antimicrobial Agents 44:4, pages 281-289.
Crossref
Crossref
Deborah E.A. Lockhart, Alexander Schuettelkopf, David E. Blair & Daan M.F. van Aalten. (2014)
Screening‐based discovery of
Aspergillus fumigatus
plant‐type chitinase inhibitors
. FEBS Letters 588:17, pages 3282-3290.
Crossref
Crossref
Chris Stockmann, Jonathan E. Constance, Jessica K. Roberts, Jared Olson, Elizabeth H. Doby, Krow Ampofo, Justin Stiers, Michael G. Spigarelli & Catherine M. T. Sherwin. (2014) Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications. Clinical Pharmacokinetics 53:5, pages 429-454.
Crossref
Crossref
Nathan P. Wiederhold, Gennethel J. Pennick, Sheryl A. Dorsey, Wieslaw Furmaga, James S. LewisIIII, Thomas F. Patterson, Deanna A. Sutton & Annette W. Fothergill. (2014) A Reference Laboratory Experience of Clinically Achievable Voriconazole, Posaconazole, and Itraconazole Concentrations within the Bloodstream and Cerebral Spinal Fluid. Antimicrobial Agents and Chemotherapy 58:1, pages 424-431.
Crossref
Crossref